(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of -1.21% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.
Neogen's revenue in 2025 is $886,886,000.On average, 3 Wall Street analysts forecast NEOG's revenue for 2026 to be $178,605,998,057, with the lowest NEOG revenue forecast at $177,467,787,854, and the highest NEOG revenue forecast at $180,204,881,347. On average, 3 Wall Street analysts forecast NEOG's revenue for 2027 to be $182,425,673,305, with the lowest NEOG revenue forecast at $180,640,347,794, and the highest NEOG revenue forecast at $184,508,263,337.
In 2028, NEOG is forecast to generate $185,650,167,616 in revenue, with the lowest revenue forecast at $185,638,216,192 and the highest revenue forecast at $185,662,119,041.